Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126854471 | 12685447 | 1 | I | 201606 | 20160616 | 20160825 | 20160825 | PER | US-NOVOPROD-498639 | NOVO NORDISK | 81.00 | YR | E | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126854471 | 12685447 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | FS6W901 | 22341 | SOLUTION FOR INJECTION | |||||||||
126854471 | 12685447 | 2 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 50 U, BID | UNKNOWN | 0 | 50 | DF | SOLUTION FOR INJECTION | BID | |||||
126854471 | 12685447 | 3 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | SLIDING SCALE | UNKNOWN | 0 | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126854471 | 12685447 | 1 | Type 2 diabetes mellitus |
126854471 | 12685447 | 2 | Type 2 diabetes mellitus |
126854471 | 12685447 | 3 | Type 2 diabetes mellitus |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126854471 | 12685447 | Abdominal discomfort | |
126854471 | 12685447 | Constipation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126854471 | 12685447 | 1 | 201606 | 0 |